Shadlen MF - Search Results

1

Alzheimer's disease symptom severity in blacks and whites.

Shadlen MF, Larson EB, Gibbons L, McCormick WC, Teri L. Shadlen MF, et al. J Am Geriatr Soc. 1999 Apr;47(4):482-6. doi: 10.1111/j.1532-5415.1999.tb07244.x. J Am Geriatr Soc. 1999. PMID: 10203126

2

Research agenda for understanding Alzheimer disease in diverse populations: work group on cultural diversity, Alzheimer's association.

Shadlen MF, McCormick WC, Larson EB. Shadlen MF, et al. Alzheimer Dis Assoc Disord. 2002;16 Suppl 2:S96-S100. doi: 10.1097/00002093-200200002-00012. Alzheimer Dis Assoc Disord. 2002. PMID: 12351923 Review.

3

Survival after initial diagnosis of Alzheimer disease.

Larson EB, Shadlen MF, Wang L, McCormick WC, Bowen JD, Teri L, Kukull WA. Larson EB, et al. Among authors: shadlen mf. Ann Intern Med. 2004 Apr 6;140(7):501-9. doi: 10.7326/0003-4819-140-7-200404060-00008. Ann Intern Med. 2004. PMID: 15068977

4

Ethnicity and cognitive performance among older African Americans, Japanese Americans, and Caucasians: the role of education.

Shadlen MF, Larson EB, Gibbons LE, Rice MM, McCormick WC, Bowen J, McCurry SM, Graves AB. Shadlen MF, et al. J Am Geriatr Soc. 2001 Oct;49(10):1371-8. doi: 10.1046/j.1532-5415.2001.49269.x. J Am Geriatr Soc. 2001. PMID: 11890499

5

Education modifies the effect of apolipoprotein epsilon 4 on cognitive decline.

Shadlen MF, Larson EB, Wang L, Phelan EA, McCormick WC, Jolley L, Teri L, van Belle G. Shadlen MF, et al. Neurobiol Aging. 2005 Jan;26(1):17-24. doi: 10.1016/j.neurobiolaging.2004.03.005. Neurobiol Aging. 2005. PMID: 15585342

6

What's new in Alzheimer's disease treatment? Reasons for optimism about future pharmacologic options.

Shadlen MF, Larson EB. Shadlen MF, et al. Postgrad Med. 1999 Jan;105(1):109-18. doi: 10.3810/pgm.1999.01.500. Postgrad Med. 1999. PMID: 9924498 Review.

7

The epidemiology of Alzheimer's disease and vascular dementia in Japanese and African-American populations: the search for etiological clues.

Shadlen MF, Larson EB, Yukawa M. Shadlen MF, et al. Neurobiol Aging. 2000 Mar-Apr;21(2):171-81. doi: 10.1016/s0197-4580(00)00115-9. Neurobiol Aging. 2000. PMID: 10867202 Review. No abstract available.

8

Education, cognitive test scores, and black-white differences in dementia risk.

Shadlen MF, Siscovick D, Fitzpatrick AL, Dulberg C, Kuller LH, Jackson S. Shadlen MF, et al. J Am Geriatr Soc. 2006 Jun;54(6):898-905. doi: 10.1111/j.1532-5415.2006.00747.x. J Am Geriatr Soc. 2006. PMID: 16776783

9

Effects of age and ethnicity on the link between APOE epsilon4 and Alzheimer disease.

Shadlen MF. Shadlen MF. JAMA. 1998 Feb 25;279(8):581; author reply 581-2. JAMA. 1998. PMID: 9486747 No abstract available.

10

Misuse of durable power of attorney for health care.

Goldstein MK, Shadlen MF. Goldstein MK, et al. Among authors: shadlen mf. J Am Geriatr Soc. 1991 Jul;39(7):730. doi: 10.1111/j.1532-5415.1991.tb03632.x. J Am Geriatr Soc. 1991. PMID: 2061542 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

10 results

Search Page